Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer

Kunio Okamoto, Isamu Okamoto, Masaki Miyazaki, Kaoru Tanaka, Hiroyasu Kaneda, Kazuhiko Nakagawa

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


We report contemporaneous bronchoscopic findings for a case of bevacizumab-related pulmonary hemorrhage in a patient with advanced non-small cell lung cancer (NSCLC). Flexible bronchoscopy at diagnosis revealed abnormal capillary dilation that was suggestive of endobronchial involvement at the primary tumor location. The patient developed massive hemoptysis despite of marked tumor shrinkage achieved by bevacizumab-containing chemotherapy. Emergency flexible bronchoscopy for hemoptysis suggested that the location of the primary tumor was the source of bleeding. Subsequent follow-up flexible bronchoscopy revealed an ulcerative mucosal-like lesion associated with a white necrotic substance as well as attenuation of the dilation of submucosal vessels compared with that apparent at diagnosis. Our case report highlights the potential mechanistic insights into bevacizumab-related bleeding and importance of performing bronchoscopy at diagnosis in NSCLC patients, given that abnormal bronchoscopic findings may be a risk factor for bleeding.

Original languageEnglish
Pages (from-to)1364-1366
Number of pages3
JournalInvestigational New Drugs
Issue number5
Publication statusPublished - Oct 2013
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this